Max Robotics — Global Service Robot Directory + US Certification

About

Detlef Imhoff is a radiation oncology researcher whose work has significantly advanced the field of stereotactic body radiation therapy (SBRT) and robotic radiosurgery, with a particular focus on optimizing treatment precision and clinical outcomes across multiple tumor sites. His contributions span spinal radiosurgery, liver and lung metastases, and prostate cancer, establishing him as a versatile and impactful figure in modern radiotherapy. Imhoff's most influential work includes co-authoring a landmark international multi-institutional benchmark trial on inverse treatment planning for spinal robotic radiosurgery (37 citations), helping to standardize optimization approaches across institutions worldwide. His research on mean GTV dose-optimized SBRT demonstrated compelling clinical results for both liver (33 citations) and lung tumors (30 citations), treating hundreds of patients with rigorous real-time motion compensation techniques. His pioneering work on breathing-motion-compensated robotic SBRT (29 citations) further underscores his commitment to therapeutic precision. In prostate cancer, Imhoff led Germany's first prospective multicenter phase II trial of hypofractionated robotic SBRT — the HYPOSTAT trial — advancing minimally invasive treatment protocols for localized disease. With cumulative citations exceeding 180, his body of work reflects both scientific rigor and meaningful clinical translation.